The Children's Place, Inc.
The Children's Place, Inc. (PLCE) Financial Performance & Income Statement Overview
Analyze The Children's Place, Inc. (PLCE) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
The Children's Place, Inc. (PLCE) Income Statement & Financial Overview
Explore comprehensive income reports for The Children's Place, Inc. PLCE, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $242.13M | $408.56M | $390.17M | $319.65M |
Cost of Revenue | $171.34M | $291.98M | $251.83M | $207.86M |
Gross Profit | $70.78M | $116.58M | $138.34M | $111.79M |
Gross Profit Ratio | $0.29 | $0.29 | $0.35 | $0.35 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $86.67M | $100.57M | $99.82M | $96.06M |
Operating Expenses | $94.90M | $109.78M | $109.08M | $133.57M |
Total Costs & Expenses | $266.24M | $401.76M | $360.92M | $341.43M |
Interest Income | $10000.00 | $8000.00 | $14000.00 | $14000.00 |
Interest Expense | $8.57M | $8.72M | $10.09M | $9.24M |
Depreciation & Amortization | $8.23M | $9.21M | $9.27M | $9.51M |
EBITDA | -$15.88M | $16.02M | $38.54M | -$12.26M |
EBITDA Ratio | -$0.07 | $0.04 | $0.10 | -$0.04 |
Operating Income | -$24.12M | $6.80M | $29.26M | -$21.78M |
Operating Income Ratio | -$0.10 | $0.02 | $0.07 | -$0.07 |
Other Income/Expenses (Net) | -$8.56M | -$8.72M | -$10.08M | -$9.23M |
Income Before Tax | -$32.68M | -$1.91M | $19.18M | -$31.007M |
Income Before Tax Ratio | -$0.13 | -$0.005 | $0.05 | -$0.10 |
Income Tax Expense | $1.34M | $6.08M | -$900000.00 | $1.11M |
Net Income | -$34.02M | -$7.99M | $20.08M | -$32.11M |
Net Income Ratio | -$0.14 | -$0.02 | $0.05 | -$0.10 |
EPS | -$2.66 | -$0.63 | $1.57 | -$2.51 |
Diluted EPS | -$2.66 | -$0.63 | $1.57 | -$2.51 |
Weighted Avg Shares Outstanding | $12.80M | $12.80M | $12.78M | $12.77M |
Weighted Avg Shares Outstanding (Diluted) | $12.80M | $12.80M | $12.80M | $12.77M |
Over the past four quarters, The Children's Place, Inc. demonstrated steady revenue growth, increasing from $319.65M in Q2 2024 to $242.13M in Q1 2025. Operating income reached -$24.12M in Q1 2025, maintaining a consistent -10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$15.88M, reflecting operational efficiency. Net income dropped to -$34.02M, with EPS at -$2.66. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan